Archive | 2019

Therapeutic effect of rosuvastatin combined with memantine hydrochloride on vascular dementia

 
 

Abstract


Objective \nTo investigate the efficacy and safety of rosuvastatin combined with memantine hydrochloride in the treatment of vascular dementia. \n \n \nMethods \nSixty-six patients with vascular dementia admitted to the Hospital of Zhejiang Provincial Armed Police Force and Haining Kanghua Hospital from January 2016 to January 2018 were enrolled.According to the digital table, the patients were divided into the observation group and the control group, with 33 cases in each group.Both two groups were given routine treatment.The control group was treated with rosuvastatin, and the observation group was given rosuvastatin combined with memantine hydrochloride.Both two groups were treated for 12 weeks.The ADL score and MoCA score, oxidative stress index, inflammatory factor, cerebral kinetic index changes, clinical efficacy and adverse reactions after treatment were compared between the two groups. \n \n \nResults \nThe therapeutic effect of the observation group was 87.88%(29/33), which was significantly higher than 63.64%(21/33) of the control group (χ2=5.280, P=0.022). After treatment, the ADL, MoCA, SOD levels, Vmax and BHI of the observation group were (41.26±5.37)points , (24.23±1.71)points, (112.27±15.35)μU/L, (65.15±11.75)cm/s, (0.79±0.36), respectively, which were higher than those of the control group [(36.19±4.07)points, (20.25±1.46)points, (93.84±12.76)μU/L, (59.15±11.74)cm/s, (0.58±0.26)], the differences were statistically significant (t=4.322, 10.168, 5.304, 2.075, 2.846, all P 0.05). \n \n \nConclusion \nThe clinical efficacy of rosuvastatin combined with memantine hydrochloride in the treatment of patients with vascular dementia can significantly reduce oxidative stress and inflammatory response, improve cerebral hemodynamics and cognitive function, and improve patients’ quality of life. \n \n \nKey words: \nDementia, vascular;\xa0Oxidative stress;\xa0Inflammation;\xa0Comparative effectiveness research;\xa0Rosuvastatin;\xa0Memantine hydrochloride

Volume 26
Pages 2105-2109
DOI 10.3760/CMA.J.ISSN.1008-6706.2019.17.014
Language English
Journal None

Full Text